Efficacy of entecavir monotherapy in nucleoside-naive patients with chronic hepatitis B in a tertiary clinic setting

被引：0
|
作者：
Davison, S. A. [1 ]
Dobbins, T. A. [1 ]
Segaert, N. [1 ]
Koorey, D. J. [1 ]
Shackel, N. A. [1 ]
Bye, W. A. [1 ]
Selby, W. S. [1 ]
McCaughan, G. W. [1 ]
Strasser, S. I. [1 ]
机构：
[1] Royal Prince Alfred Hosp, AW Morrow Gastroenterol & Liver Ctr, Camperdown, NSW 2050, Australia
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2009年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A282 / A282
页数：1
相关论文
共 50 条
  • [21] A case of entecavir resistance which is developed after complete viral suppression during entecavir treatment for nucleoside-naive chronic hepatitis B
    Dogan, Umit Bilge
    Ozturk, Agah Bahadir
    Akin, Mustafa Salih
    Yalaki, Serkan
    Sayan, Murat
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2014, 25 : 206 - 209
  • [22] Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naive HBeAg-positive patients with chronic hepatitis B
    Chang, T. -T.
    Chao, Y. -C.
    Gorbakov, V. V.
    Han, K. -H.
    Gish, R. G.
    de Man, R.
    Cheinquer, H.
    Bessone, F.
    Brett-Smith, H.
    Tamez, R.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (11) : 784 - 789
  • [23] Quantitative hepatitis B surface antigen analysis in hepatitis B e antigen-positive nucleoside-naive patients treated with entecavir
    Gish, Robert G.
    Chang, Ting-Tsung
    Lai, Ching-Lung
    de Man, Robert A.
    Gadano, Adrian
    Llamoso, Cyril
    Tang, Hong
    ANTIVIRAL THERAPY, 2013, 18 (05) : 691 - 698
  • [24] Efficacy of prolonged entecavir monotherapy in treatment-naive chronic hepatitis B patients exhibiting a partial virologic response to entecavir
    Choi, Han Na
    Song, Jeong Eun
    Lee, Hyeon Chul
    Jo, Hyeong Ho
    Lee, Chang Hyeong
    Kim, Byung Seok
    CLINICAL AND MOLECULAR HEPATOLOGY, 2015, 21 (01) : 24 - 31
  • [25] Selection of a virus strain resistant to entecavir in a nucleoside-naive patient with hepatitis B of genotype H
    Suzuki, Fumitaka
    Akuta, Norio
    Suzuki, Yoshiyuki
    Yatsuji, Hiromi
    Sezaki, Hitomi
    Arase, Yasuji
    Kawamura, Yusuke
    Hosaka, Tetsuya
    Kobayashi, Masahiro
    Ikeda, Kenji
    Kobayashi, Mariko
    Watahiki, Sachiyo
    Kumada, Hiromitsu
    JOURNAL OF CLINICAL VIROLOGY, 2007, 39 (02) : 149 - 152
  • [26] Entecavir is well-tolerated for treatment of chronic hepatitis B: Phase III safety analysis in nucleoside-naive and lamivudine-refractory patients
    Sollano, J
    Schiff, E
    Carrilho, F
    Raptopoulou-Gigi, M
    Cooney, E
    Hindes, R
    Cross, A
    Dehertogh, D
    HEPATOLOGY, 2004, 40 (04) : 665A - 665A
  • [27] Entecavir resistance is rare in nucleoside naive patients with hepatitis B
    Colonno, Richard J.
    Rose, Ronald
    Baldick, Carl J.
    Levine, Steven
    Pokornowski, Kevin
    Yu, Cheng F.
    Walsh, Ann
    Fang, Jie
    Hsu, Mayla
    Mazzucco, Charles
    Eggers, Betsy
    Zhang, Sharon
    Plym, Mary
    Klesczewski, Kenneth
    Tenney, Daniel J.
    HEPATOLOGY, 2006, 44 (06) : 1656 - 1665
  • [28] Entecavir is superior to lamivudine for the treatment of HBeAg(+) chronic hepatitis B: Results of phase III study ETV-022 in nucleoside-naive patients
    Chang, TT
    Gish, R
    de Man, R
    Gadano, A
    Sollano, J
    Han, KH
    Goodman, Z
    Zhu, J
    Cross, A
    Dehertogh, D
    Apelian, D
    HEPATOLOGY, 2004, 40 (04) : 193A - 193A
  • [29] Entecavir is well-tolerated for treatment of chronic hepatitis B: Phase III safety analysis in nucleoside-naive and lamivudine-refractory patients
    Sollano, J
    Schiff, E
    Carrilho, F
    Raptopoulou-Gigi, M
    Cooney, E
    Hindes, R
    Cross, A
    DeHertogh, D
    ANTIVIRAL THERAPY, 2004, 9 (06) : H24 - H24
  • [30] Comparable efficacy with entecavir monotherapy and tenofovir-entecavir combination in chronic hepatitis B patients
    Baqai, Sumbella
    Proudfoot, James
    Xu, Ronghui
    Kane, Steve
    Clark, Margaret
    Gish, Robert
    BMJ OPEN GASTROENTEROLOGY, 2015, 2 (01):
12345